RTI Board Member Jonathon Singer Named Chief
Financial and Administrative Officer;
Brings 30 Years of Strategic and Operational
Experience to RTI
RTI also Appoints Olivier Visa as President
of OEM, Donor Services and Sports and Julius Aviza as Vice
President, Quality Assurance
RTI Surgical Inc. (RTI) (Nasdaq:RTIX), a leading global surgical
implant company, announced today three new appointments to its
senior leadership team to accelerate the Company’s strategic growth
initiatives. They include Jonathon Singer, a member of RTI’s board
of directors, as Chief Financial and Administrative Officer,
effective October 2, 2017. Outgoing CFO Robert Jordheim will leave
the company to pursue new endeavors following a successful
transition. RTI also appointed Olivier Visa, formerly Vice
President of Global Compounding for Baxter, and Julius Aviza, past
Vice President of Global Quality at American Medical Systems, to
lead its OEM, Donor Services, Sports business and quality assurance
function, respectively.
The new management additions demonstrate another important step
toward positioning RTI for continued progress in executing its
strategic transformation plan. The augmented leadership team has
decades of highly specialized functional and industry expertise,
along with a diverse skill set that is aligned to build on RTI’s
recent strong performance and to advance its progress toward
returning RTI to long-term sustainable growth and profitability.
Each leader will play a critical role in further developing their
respective functional excellence, streamlining RTI’s businesses,
upgrading its processes and reinforcing a culture that is laser
focused on the customer.
New Chief Financial and Administrative Officer
Mr. Singer, an RTI board member since May 2016, will resign from
the board to focus on his new role, which includes managing the
company’s financial operations and overseeing RTI’s information
technology, legal and business development functions. He will
report to RTI Chief Executive Officer Camille Farhat.
“As we continue to implement our long-term growth strategy, we
need the right team to accelerate and solidify our progress,” said
Mr. Farhat. “I am particularly proud to welcome Jonathon who
already has been a valuable contributor to RTI’s progress as one of
our board members. His intricate knowledge of RTI combined with his
broad business experience and deep background in strategic
planning, finance, operations, IT, investor communications and
business development will bring a new dimension to his role and
help us accomplish the significant work ahead of us.”
Mr. Singer has more than 30 years of leadership experience at
publicly-traded health care and pharmaceutical organizations.
Previously, he was Executive Vice President and Chief Financial
Officer at Sagent Pharmaceuticals, a producer of generic injectable
products that won numerous awards for growth and innovation during
his tenure. Mr. Singer also served as CFO of Landauer, a radiation
safety products and services provider, and as Vice President for
Global Finance and CFO of the Medical Segment at specialty medical
device company, Teleflex. A certified public accountant, he has
held finance, accounting and operations roles at Cardinal Health,
R.R. Donnelley & Sons and KPMG.
“I would like to extend my appreciation and gratitude to Rob
Jordheim for his service as CFO and interim CEO,” said Mr. Farhat.
“His commitment to RTI’s mission has contributed to putting us back
on the path toward growth. We all wish Rob the best in his future
endeavors.”
Additional Leadership Appointments
Further building out its management team, RTI appointed Olivier
Visa as its President of OEM, Donor Services and Sports, and Julius
Aviza to the role of Vice President, Global Quality Assurance. Mr.
Visa has 25 years of commercial leadership experience in the global
health care industry, with a focus on transforming businesses and
building sustainable value. He joins RTI from Baxter Healthcare
Corporation, where he was Vice President of Global Compounding,
responsible for overseeing global profitability improvement of the
outsourcing pharmacy business and ensuring that operations, quality
and research and development focused on patient safety and
innovation. Mr. Visa succeeds Roger Rose, President of Donor
Services and OEM, who is leaving RTI to seek new opportunities.
Mr. Aviza, who previously was Vice President of Global Quality
at American Medical Systems (AMS), has over 20 years of global
Quality Assurance and leadership experience focused on building and
implementing scalable quality systems. His expertise spans the
medical devices sector, across new product development, sustaining
engineering and operations. He has a track record of resolving
quality and compliance issues and driving organizational
effectiveness for multiple medical device companies including AMS,
Allergan, GE Healthcare, Baxter and Abbott Laboratories. Mr. Aviza
succeeds Bryan Martin, Vice President of Quality, who is leaving
RTI to pursue other opportunities.
“Olivier and Julius are highly experienced executives with
proven success in the health care sector who share our values of a
customer-focused culture built around speed, competence, and
predictable execution and growth,” said Mr. Farhat. “Olivier will
be critical to furthering growth in RTI’s OEM business and driving
operational excellence and profitability in its tissue business.
Julius will work vigorously to ensure that our quality systems are
at industry-leading standards while simplifying our processes to
create a solid platform from which we can grow.”
He added: “I would like to thank Roger for his years of service
to RTI’s customers and patients, and his passion for maximizing the
gift of life and his leadership in initiating our operational
excellence efforts with our valued partners on the tissue business.
I also would like to thank Bryan for his hard work in stepping in
and stabilizing our quality function.”
RTI continues to augment its leadership team having recently
announced the appointments of Paul Montague as Vice President,
Human Resources and Enrico Sangiorgio as Vice President &
General Manager, International Markets. RTI is also recruiting for
top research and development positions.
About RTI Surgical Inc.
RTI Surgical is a leading global surgical implant company
providing surgeons with safe biologic, metal and synthetic
implants. Committed to delivering a higher standard, RTI’s implants
are used in sports medicine, general surgery, spine, orthopedic,
trauma and cardiothoracic procedures and are distributed in nearly
50 countries. RTI is headquartered in Alachua, Fla., and has four
manufacturing facilities throughout the U.S. and Europe. RTI is
accredited in the U.S. by the American Association of Tissue Banks
and is a member of AdvaMed. For more information, please visit
www.rtix.com.
Forward-Looking Statement
This communication contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. These forward-looking statements are based on management’s
current expectations, estimates and projections about our industry,
our management's beliefs and certain assumptions made by our
management. Words such as "anticipates," "expects," "intends,"
"plans," "believes," "seeks," "estimates," variations of such words
and similar expressions are intended to identify such
forward-looking statements. In addition, except for historical
information, any statements made in this communication about
anticipated financial results, growth rates, new product
introductions, future operational improvements and results or
regulatory actions or approvals or changes to agreements with
distributors also are forward-looking statements. These statements
are not guarantees of future performance and are subject to risks
and uncertainties, including the risks described in public filings
with the U.S. Securities and Exchange Commission (SEC). Our actual
results may differ materially from the anticipated results
reflected in these forward-looking statements. Copies of the
company's SEC filings may be obtained by contacting the company or
the SEC or by visiting RTI's website at www.rtix.com or the SEC's
website at www.sec.gov.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170918006508/en/
RTI Surgical Inc.Roxane Wergin, 386-418-8888Director,
Corporate Communicationsrwergin@rtix.com
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Mar 2024 to Apr 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Apr 2023 to Apr 2024